<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03174002</url>
  </required_header>
  <id_info>
    <org_study_id>AAUH-ICU-01</org_study_id>
    <secondary_id>2017-000632-34</secondary_id>
    <nct_id>NCT03174002</nct_id>
  </id_info>
  <brief_title>Handling Oxygenation Targets in the Intensive Care Unit</brief_title>
  <acronym>HOT-ICU</acronym>
  <official_title>Handling Oxygenation Targets in Adults With Acute Hypoxaemic Respiratory Failure in the Intensive Care Unit: A Randomised Clinical Trial of a Lower Versus a Higher Oxygenation Target</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aalborg Universitetshospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Copenhagen Trial Unit, Center for Clinical Intervention Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aalborg Universitetshospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Handling oxygenation targets (HOT) is standard of care in the intensive care unit (ICU),
      however the quality and quantity of evidence is low and potential harm has been reported. The
      aim of the HOT-ICU trial is to assess the overall benefits and harms of two levels of
      oxygenation targets in adult critically ill patients with acute hypoxaemic respiratory
      failure in the ICU.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acutely ill adults with hypoxaemic respiratory failure admitted to the intensive care unit
      (ICU) are at risk of life-threatening hypoxia, and thus oxygen is administered. However, the
      evidence on the optimal level of oxygenation is of low quantity and quality with no firm
      evidence for benefit or harm. Importantly, liberal use of supplementary oxygen may increase
      the number of serious adverse events including death. The aim of the HOT-ICU trial is to
      assess the benefits and harms of two targets of partial pressure of oxygen in arterial blood
      (PaO2) in guiding the oxygen administration in acutely ill adults with hypoxaemic respiratory
      failure at ICU admission.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 19, 2017</start_date>
  <completion_date type="Anticipated">June 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 15, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>90 days</time_frame>
    <description>Landmark mortality 90-days after randomisation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Days alive without organ support</measure>
    <time_frame>Within 90 days</time_frame>
    <description>Percentage of days alive and free from mechanical ventilation, circulatory support and renal replacement therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days alive out of the hospital</measure>
    <time_frame>Within 90 days</time_frame>
    <description>Percentage of days alive out of the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with one or more serious adverse events</measure>
    <time_frame>Until ICU discharge, maximum 90 days</time_frame>
    <description>Serious adverse events are defined as new episode of shock and new episodes of ischaemic events including myocardial or intestinal ischaemia or ischaemic stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>1 year</time_frame>
    <description>Landmark mortality 1 year after randomisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1 year</time_frame>
    <description>EQ-5D-5L 1-year after randomisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function 1-year after randomisation as assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) score in selected sites</measure>
    <time_frame>1 year</time_frame>
    <description>RBANS score 1 year after randomisation at selected sites</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A health economic analysis</measure>
    <time_frame>90 days</time_frame>
    <description>The analytic details will be based on the result of the trial and specified (cost-effectiveness versus cost-minimisation analyses)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2928</enrollment>
  <condition>Hypoxemic Respiratory Failure</condition>
  <condition>Oxygen Toxicity</condition>
  <arm_group>
    <arm_group_label>Low oxygenation target</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Partial pressure of oxygen in arterial blood (PaO2) 8 kPa (60 mmHg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High oxygenation target</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Partial pressure of oxygen in arterial blood (PaO2) 12 kPa (90 mmHg)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxygen</intervention_name>
    <description>Oxygen administration to achieve a PaO2 of 8 kPa (60 mmHg) from ICU admission to ICU discharge</description>
    <arm_group_label>Low oxygenation target</arm_group_label>
    <other_name>Inspired oxygen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxygen</intervention_name>
    <description>Oxygen administration to achieve a PaO2 of 12 kPa (90 mmHg) from ICU admission to ICU discharge</description>
    <arm_group_label>High oxygenation target</arm_group_label>
    <other_name>Inspired oxygen</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acutely admitted to the ICU AND

          -  Aged ≥ 18 years AND

          -  Receives supplemental oxygen with a flow of at least 10 L per minutes in an open
             system including high-flow systems OR at least a FiO2 of 0.50 in a closed system
             including invasive or non-invasive ventilation or CPAP systems AND

          -  Expected to receive supplemental oxygen for at least 24 hours in the ICU AND

          -  Having an arterial line for PaO2 monitoring

        Exclusion Criteria:

          -  Cannot be randomised within twelve hours after present ICU admission

          -  Chronic mechanical ventilation for any reason

          -  Use of home oxygen

          -  Previous treatment with bleomycin

          -  Organ transplant during current hospital admission

          -  Withdrawal from active therapy or brain death deemed imminent

          -  Fertile woman (&lt; 50 years of age) with positive urine human gonadotropin (hCG) or
             plasma-hCG

          -  Carbon monoxide poisoning

          -  Cyanide poisoning

          -  Methaemoglobinaemia

          -  Paraquat poisoning

          -  Any condition expected to involve the use of hyperbaric oxygen (HBO)

          -  Sickle cell disease

          -  Consent not obtainable according to national regulations

          -  Previously randomised into the HOT-ICU trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bodil Steen Rasmussen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aalborg University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anders Perner, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bodil Steen Rasmussen, MD, PhD</last_name>
    <phone>+4597661864</phone>
    <email>bodil.steen.rasmussen@rn.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Olav Lilleholt Schjørring, MD</last_name>
    <phone>+4597661921</phone>
    <email>o.schjoerring@rn.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Aalborg University Hospital</name>
      <address>
        <city>Aalborg</city>
        <zip>9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olav L Schjørring, MD</last_name>
      <email>o.schjoerring@rn.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Aarhus University Hospital Nørrebrogade</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Helle Nibro, MD</last_name>
      <email>hellnibr@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Aarhus University Hospital Tage Hansensgade</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans M Betsch, MD</last_name>
      <email>hansbets@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, University Hospital Skejby</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steffen Christensen, MD</last_name>
      <email>steffen.christensen@auh.rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care 4131, Copenhagen University Hospital Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bjørn Brand, MD</last_name>
      <email>bjoern.brand@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian S Meyhoff, MD</last_name>
      <email>christian.saltholt.meyhoff@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Herlev Hospital</name>
      <address>
        <city>Herlev</city>
        <zip>2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hernrik Christensen, MD</last_name>
      <email>henrik.christensen@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Herning Hospital</name>
      <address>
        <city>Herning</city>
        <zip>7400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Winding, MD</last_name>
      <email>robewing@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Hillerød Hospital</name>
      <address>
        <city>Hillerød</city>
        <zip>3400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Morten Bestle, MD, PhD</last_name>
      <email>morten.bestle@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Hjørring Hospital</name>
      <address>
        <city>Hjørring</city>
        <zip>9800</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mary Kruse, MD</last_name>
      <email>mary.kruse@rn.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Holbæk Hospital</name>
      <address>
        <city>Holbæk</city>
        <zip>4300</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans H Bülow, MD</last_name>
      <email>hhbu@regionsjaelland.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Intensive Care, Holstebro</name>
      <address>
        <city>Holstebro</city>
        <zip>7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nilanjan Dey, MD</last_name>
      <phone>+4578432827</phone>
      <email>nildey@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Holstebro Hospital</name>
      <address>
        <city>Holstebro</city>
        <zip>7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nilanjan Dey, MD</last_name>
      <email>nildey@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Horsens Hospital</name>
      <address>
        <city>Horsens</city>
        <zip>8700</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lone Buus, MD</last_name>
      <phone>+4578425000</phone>
      <email>lonebuus@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Hvidovre Hospital</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ulf G Pedersen, MD</last_name>
      <email>ulf.goettrup.pedersen@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Kolding Hospital</name>
      <address>
        <city>Kolding</city>
        <zip>6000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane S Nielsen, MD</last_name>
      <email>jane.stab.nielsen@rsyd.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Køge Hospital</name>
      <address>
        <city>Køge</city>
        <zip>4600</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerij Khridin, MD</last_name>
      <email>vkh@regionsjaelland.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Randers Hospital</name>
      <address>
        <city>Randers</city>
        <zip>8930</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thorbjørn Grøfte, MD</last_name>
      <email>thorgroe@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Roskilde Hospital</name>
      <address>
        <city>Roskilde</city>
        <zip>4000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Hildebrandt Walli, MD</last_name>
      <email>thi@regionsjaelland.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Slagelse Hospital</name>
      <address>
        <city>Slagelse</city>
        <zip>4200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susanne A Iversen, MD</last_name>
      <email>saiv@regionsjaelland.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Vejle Hospital</name>
      <address>
        <city>Vejle</city>
        <zip>7100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Department of Intensive Care, Viborg Hospital</name>
      <address>
        <city>Viborg</city>
        <zip>8800</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoffer G Sølling, MD</last_name>
      <email>chrsoell@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marjatta Okkonen, MD</last_name>
      <email>marjatta.okkonen@hus.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Landspitali University Hospital Reykjavik</name>
      <address>
        <city>Reykjavík</city>
        <country>Iceland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katrin M Thormar, MD</last_name>
      <email>katrinthormar@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9713</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric Keus, MD</last_name>
      <email>f.keus@umcg.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, National Hospital, University of Oslo</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jon H Laake, MD</last_name>
      <email>jhlaake@me.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Linköping University Hospital</name>
      <address>
        <city>Linköping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Basel University Hospital</name>
      <address>
        <city>Basel</city>
        <zip>4056</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Siegemund, MD</last_name>
      <email>martin.siegemund@usb.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Bern University Hospital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joerg C Schefold, MD</last_name>
      <email>joerg.schefold@insel.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Intensive Care and Anaesthesia</name>
      <address>
        <city>Cardiff</city>
        <state>Wales</state>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tamas Szakmany, MD</last_name>
      <email>tamas.szakmany@wales.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Finland</country>
    <country>Iceland</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.cric.nu/hot-icu</url>
    <description>Link to the HOT-ICU website</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 30, 2017</study_first_submitted>
  <study_first_submitted_qc>June 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2017</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aalborg Universitetshospital</investigator_affiliation>
    <investigator_full_name>Bodil Steen Rasmussen</investigator_full_name>
    <investigator_title>Clinical Professor, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Oxygenation</keyword>
  <keyword>Acute Respiratory Distress Syndrome</keyword>
  <keyword>Mechanical ventilation</keyword>
  <keyword>Critical illness</keyword>
  <keyword>Critical care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

